Owens & Minor (OMI) Competitors $7.86 -0.08 (-0.96%) Closing price 03:59 PM EasternExtended Trading$7.88 +0.02 (+0.27%) As of 06:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock OMI vs. HSIC, MCK, COR, CAH, PDCO, QDEL, LMAT, ATRC, PAHC, and AHCOShould you be buying Owens & Minor stock or one of its competitors? The main competitors of Owens & Minor include Henry Schein (HSIC), McKesson (MCK), Cencora (COR), Cardinal Health (CAH), Patterson Companies (PDCO), QuidelOrtho (QDEL), LeMaitre Vascular (LMAT), AtriCure (ATRC), Phibro Animal Health (PAHC), and AdaptHealth (AHCO). These companies are all part of the "medical" sector. Owens & Minor vs. Its Competitors Henry Schein McKesson Cencora Cardinal Health Patterson Companies QuidelOrtho LeMaitre Vascular AtriCure Phibro Animal Health AdaptHealth Owens & Minor (NYSE:OMI) and Henry Schein (NASDAQ:HSIC) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, dividends, earnings, institutional ownership, risk, profitability, valuation and analyst recommendations. Which has higher earnings & valuation, OMI or HSIC? Henry Schein has higher revenue and earnings than Owens & Minor. Owens & Minor is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOwens & Minor$10.70B0.06-$362.69M-$4.75-1.66Henry Schein$12.67B0.69$390M$3.2022.33 Which has more volatility & risk, OMI or HSIC? Owens & Minor has a beta of 1.4, meaning that its share price is 40% more volatile than the S&P 500. Comparatively, Henry Schein has a beta of 0.87, meaning that its share price is 13% less volatile than the S&P 500. Do institutionals and insiders believe in OMI or HSIC? 98.0% of Owens & Minor shares are owned by institutional investors. Comparatively, 96.6% of Henry Schein shares are owned by institutional investors. 3.7% of Owens & Minor shares are owned by company insiders. Comparatively, 1.1% of Henry Schein shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Do analysts recommend OMI or HSIC? Owens & Minor currently has a consensus target price of $11.60, indicating a potential upside of 47.51%. Henry Schein has a consensus target price of $78.08, indicating a potential upside of 9.27%. Given Owens & Minor's higher possible upside, equities analysts clearly believe Owens & Minor is more favorable than Henry Schein.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Owens & Minor 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20Henry Schein 0 Sell rating(s) 8 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.33 Does the media refer more to OMI or HSIC? In the previous week, Henry Schein had 7 more articles in the media than Owens & Minor. MarketBeat recorded 10 mentions for Henry Schein and 3 mentions for Owens & Minor. Owens & Minor's average media sentiment score of 0.97 beat Henry Schein's score of 0.67 indicating that Owens & Minor is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Owens & Minor 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Henry Schein 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Is OMI or HSIC more profitable? Henry Schein has a net margin of 3.21% compared to Owens & Minor's net margin of -3.41%. Owens & Minor's return on equity of 17.09% beat Henry Schein's return on equity.Company Net Margins Return on Equity Return on Assets Owens & Minor-3.41% 17.09% 2.47% Henry Schein 3.21%14.87%5.82% SummaryHenry Schein beats Owens & Minor on 10 of the 16 factors compared between the two stocks. Get Owens & Minor News Delivered to You Automatically Sign up to receive the latest news and ratings for OMI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OMI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OMI vs. The Competition Export to ExcelMetricOwens & MinorMED PRODUCTS IndustryMedical SectorNYSE ExchangeMarket Cap$613.40M$10.55B$5.70B$21.12BDividend YieldN/A2.00%4.69%3.60%P/E Ratio-1.6617.0728.0728.44Price / Sales0.0629.18448.5760.38Price / Cash0.8923.0336.2222.92Price / Book1.073.698.664.69Net Income-$362.69M$234.77M$3.25B$995.51M7 Day Performance1.21%6.32%4.20%1.64%1 Month Performance-0.08%8.39%10.82%5.92%1 Year Performance-49.78%-13.51%34.70%11.50% Owens & Minor Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OMIOwens & Minor4.7182 of 5 stars$7.86-1.0%$11.60+47.5%-50.7%$613.40M$10.70B-1.6623,200News CoverageUpcoming EarningsHSICHenry Schein3.4044 of 5 stars$70.68-3.7%$78.36+10.9%+3.3%$8.60B$12.67B22.0925,000Analyst ForecastMCKMcKesson4.4311 of 5 stars$716.46+1.0%$706.83-1.3%+20.4%$89.64B$359.05B27.7445,000Positive NewsCORCencora4.4782 of 5 stars$297.00+0.6%$306.33+3.1%+28.5%$57.57B$638.56M34.4546,000Positive NewsInsider TradeCAHCardinal Health4.841 of 5 stars$161.70+0.5%$157.43-2.6%+63.5%$38.59B$222.29B25.2348,900Positive NewsAnalyst RevisionPDCOPatterson Companies1.7219 of 5 stars$31.33flat$26.57-15.2%N/A$2.77B$6.51B18.327,700Negative NewsQDELQuidelOrtho4.4732 of 5 stars$28.86-4.9%$44.33+53.6%-31.4%$1.95B$2.76B-5.816,600LMATLeMaitre Vascular2.6656 of 5 stars$84.09+0.5%$97.83+16.3%-10.6%$1.90B$226.26M42.47490Positive NewsAnalyst ForecastATRCAtriCure3.3253 of 5 stars$31.30+1.9%$50.67+61.9%+25.8%$1.55B$480.08M-38.641,300Positive NewsUpcoming EarningsPAHCPhibro Animal Health4.0914 of 5 stars$31.54+2.4%$24.40-22.6%+56.7%$1.28B$1.02B40.441,940Positive NewsAHCOAdaptHealth4.0437 of 5 stars$9.17-0.5%$13.40+46.1%-18.4%$1.24B$3.26B16.0910,500Positive News Related Companies and Tools Related Companies Henry Schein Alternatives McKesson Alternatives Cencora Alternatives Cardinal Health Alternatives Patterson Companies Alternatives QuidelOrtho Alternatives LeMaitre Vascular Alternatives AtriCure Alternatives Phibro Animal Health Alternatives AdaptHealth Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:OMI) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Owens & Minor, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Owens & Minor With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.